Table 1. Clinical characteristics of patients with bronchiectasis.
| Parameters | CRS | No CRS | P value |
|---|---|---|---|
| No. of patients | 47 | 101 | - |
| Age (years) | 43.6±14.8 | 45.0±13.4 | 0.58 |
| Height (cm) | 160.1±8.0 | 161.6±7.6 | 0.27 |
| Weight (kg) | 50.0 (11.5) | 52.0 (10.8) | 0.40 |
| Females (No., %) | 33 (70.2%) | 59 (58.4%) | 0.17 |
| Body mass index (kg/m 2 ) | 20.4±2.7 | 20.0 (4.3) | 0.80 |
| Body mass index <18.5 (No., %) | 11 (23.4%) | 33 (32.7%) | 0.25 |
| Age of bronchiectasis symptom onset (years) | 30.3±16.1 | 30.7±17.1 | 0.91 |
| Symptom onset for >10 years (No., %) | 19 (40.4%) | 40 (39.6%) | 0.92 |
| Duration of symptom onset (years) | 13.3±9.7 | 14.3±14.2 | 0.65 |
| 24-hour sputum volume (ml) | 20.0 (35.0) | 20.0 (25.0) | 0.44 |
| Bronchiectasis Severity Index | 6.4±3.4 | 5.0 (6.0) | 0.19 |
| Never-smokers (No., %) | 39 (83.0%) | 92 (91.1%) | 0.15 |
| Underlying causes | |||
| Post-infectious (No., %) | 10 (21.3%) | 30 (29.7%) | 0.28 |
| Other known causes (No., %) * | 18 (38.3%) | 22 (21.8%) | 0.04 |
| Idiopathic (No., %) | 19 (40.4%) | 49 (48.5%) | 0.36 |
Numerical data were presented as mean ± standard deviation for normal distribution or otherwise median (interquartile range). Categorical data were expressed as number (percentage).
Data in bold indicated the comparisons with statistical significance.
* Of all bronchiectasis patients, other known causes consisted of immunodeficiency (n = 13, 8.8%), asthma (n = 8, 5.4%), gastroesophageal reflux (n = 6, 4.1%), aspergillosis (n = 2, 1.4%), rheumatoid arthritis (n = 2, 1.4%), Kartagener syndrome (n = 2, 1.4%), lung maldevelopment (n = 2, 1.4%), Young’s syndrome (n = 1, 0.7%), COPD (n = 1, 0.7%), lung sequestration (n = 1, 0.7%), yellow nail syndrome (n = 1, 0.7%) and diffuse panbronchiolitis (n = 1, 0.7%).
None of the patients had ever used inhaled antibiotics in this study.